12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Company News  |  Deals

Warnex, Biotrial Research S.A.S. deal

Warnex will sell its Bioanalytical Services division to CRO Biotrial for C$6 million ($6 million) in cash. Warnex is also eligible for an additional payment equal to the amount by which adjusted 2012 revenues from the division exceed C$6 million. Warnex may also...

Read the full 193 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >